Faculty of Biomedical Sciences, Institute for Research in Biomedicine, Università della Svizzera italiana (USI), 6500 Bellinzona, Switzerland; email:
Department of Biology, Institute of Biochemistry, Eidgenössische Technische Hochschule (ETH) Zürich, 8093 Zürich, Switzerland.
Annu Rev Genet. 2021 Nov 23;55:285-307. doi: 10.1146/annurev-genet-071719-020312.
DNA double-strand breaks (DSBs) are cytotoxic lesions that threaten genome integrity and cell viability. Typically, cells repair DSBs by either nonhomologous end joining (NHEJ) or homologous recombination (HR). The relative use of these two pathways depends on many factors, including cell cycle stage and the nature of the DNA ends. A critical determinant of repair pathway selection is the initiation of 5'→3' nucleolytic degradation of DNA ends, a process referred to as DNA end resection. End resection is essential to create single-stranded DNA overhangs, which serve as the substrate for the Rad51 recombinase to initiate HR and are refractory to NHEJ repair. Here, we review recent insights into the mechanisms of end resection, how it is regulated, and the pathological consequences of its dysregulation.
DNA 双链断裂(DSBs)是威胁基因组完整性和细胞存活的细胞毒性损伤。通常,细胞通过非同源末端连接(NHEJ)或同源重组(HR)来修复 DSBs。这两种途径的相对使用取决于许多因素,包括细胞周期阶段和 DNA 末端的性质。修复途径选择的一个关键决定因素是启动 DNA 末端的 5'→3'核酸酶降解,这个过程称为 DNA 末端切除。末端切除对于产生单链 DNA 突出端至关重要,这些突出端是 Rad51 重组酶启动 HR 的底物,并且对 NHEJ 修复具有抗性。在这里,我们回顾了末端切除的机制、调节方式以及其失调的病理后果的最新见解。